Rafferty Asset Management’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-7,570
| Closed | -$236K | – | 1173 |
|
|
2024
Q3 | $236K | Sell |
7,570
-43
| -0.6% | -$1.34K | ﹤0.01% | 1072 |
|
|
2024
Q2 | $204K | Buy |
+7,613
| New | +$204K | ﹤0.01% | 1136 |
|
|
2022
Q1 | – | Sell |
-6,908
| Closed | -$201K | – | 1319 |
|
|
2021
Q4 | $201K | Sell |
6,908
-1,589
| -19% | -$46.2K | ﹤0.01% | 1228 |
|
|
2021
Q3 | $227K | Buy |
+8,497
| New | +$227K | ﹤0.01% | 1173 |
|
|
2019
Q4 | – | Sell |
-7,862
| Closed | -$216K | – | 902 |
|
|
2019
Q3 | $216K | Buy |
+7,862
| New | +$216K | ﹤0.01% | 773 |
|
|
2018
Q2 | – | Sell |
-56,529
| Closed | -$2.59M | – | 699 |
|
|
2018
Q1 | $2.59M | Buy |
+56,529
| New | +$2.59M | 0.04% | 228 |
|